Sharda Cropchem Analyst Review May 2026

This Sharda Cropchem analyst review for May 2026 covers the key data investors need for SHARDACROP at its current price of Rs 904.80. Sharda Cropchem (NSE: SHARDACROP) is a global agrochemical formulation company with a market capitalisation of approximately Rs 7,500 crore, marketing generic crop protection products across 80 plus countries. The analyst consensus target of Rs 1,100 implies meaningful upside, and this Sharda Cropchem analyst review examines technical levels, business performance, valuation, and key risks that will determine whether SHARDACROP achieves that target through FY27.

Click Here – Get Free Investment Predictions

Sharda Cropchem Company Snapshot May 2026

Sharda Cropchem’s asset-light business model outsources manufacturing while focusing on global distribution of generic fungicides, herbicides, and insecticides. Europe, North America, and Latin America are the primary revenue markets. The table below summarises the key data referenced in this Sharda Cropchem analyst review.

Parameter	Value
NSE Ticker	SHARDACROP
Sector	Agrochemicals – Generic Formulations and Exports
CMP (May 2026)	Rs 904.80
52 Week High	Rs 1,297.00
52 Week Low	Rs 604.00
Market Cap	Rs 7,500 Crore
Trailing P/E	18x
Analyst Consensus Target	Rs 1,100
Bull Case Target	Rs 1,380
Bear Case Target	Rs 820

Analyst Insight in This Sharda Cropchem Analyst Review

Senior Research Analyst Ankit Jaiswal flags Sharda Cropchem as a stock to watch in May 2026. At Rs 904.80, Ankit Jaiswal identifies key support in the Rs 616 to Rs 860 band and resistance near Rs 959. He suggests watching Sharda Cropchem for a potential move toward Rs 1,100, subject to Agrochemicals – Generic Formulations and Exports sector momentum and Nifty 50 direction. Ankit Jaiswal’s view is one input in this Sharda Cropchem analyst review and does not constitute a trade recommendation.

Technical Analysis in This Sharda Cropchem Analyst Review

At Rs 904.80, SHARDACROP is trading within its 52-week band of Rs 604.00 to Rs 1,297.00. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.

Near-term support is identified in the Rs 616 to Rs 860 band while resistance is seen in the Rs 959 to Rs 1002 zone. A sustained move above Rs 959 could open the path toward the analyst consensus target of Rs 1,100.

Screen the best stocks on the Univest Screener.

Key Support and Resistance Levels

• Support Zone: Rs 616 to Rs 860 – investors tracking this Sharda Cropchem analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for SHARDACROP.
• Resistance Zone: Rs 959 to Rs 1002 – a sustained close above Rs 959 would be a positive breakout signal worth flagging in this Sharda Cropchem analyst review.
• Medium-Term Target: The analyst consensus of Rs 1,100 represents the base-case upside scenario identified in this Sharda Cropchem analyst review.

Business Segment Analysis

Generic Agrochemical Formulations (Global Distribution)

This is the primary revenue and margin driver for Sharda Cropchem, directly supporting the earnings trajectory toward the consensus target of Rs 1,100.

Fungicides and Herbicides (European Market Leader)

This segment adds scale and diversification to Sharda Cropchem’s business model and is a meaningful EPS contributor through FY27 and FY28.

Latin American and North American Crop Protection

This represents the medium-term growth frontier for Sharda Cropchem and a key re-rating catalyst for the stock over the next 12 to 24 months.

Valuation in This Sharda Cropchem Analyst Review

At Rs 904.80, Sharda Cropchem trades at a trailing P/E of 18x. This Sharda Cropchem analyst review presents three valuation scenarios: a bull case of Rs 1,380 on strong earnings delivery and sector tailwinds, a base case of Rs 1,100 at analyst consensus, and a bear case of Rs 820 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Sharda Cropchem analyst review.

Scenario	Target Price	Key Condition
Bull Case	Rs 1,380	Strong earnings delivery and sector re-rating
Base Case (Consensus)	Rs 1,100	Moderate growth, analyst consensus estimate
Bear Case	Rs 820	Earnings miss or macro headwinds

Trade Outlook for Sharda Cropchem

Based on the technical and fundamental analysis in this Sharda Cropchem analyst review, investors might watch SHARDACROP near the support zone of Rs 616 to Rs 860 for potential opportunities. A flag above Rs 959 could suggest improving momentum toward Rs 1,100. This article uses watch-and-flag language only and does not constitute a trade recommendation.

Key Risks for Sharda Cropchem in FY27

A well-rounded Sharda Cropchem analyst review must assess downside risks. Key risks for Sharda Cropchem include a macro slowdown affecting Agrochemicals – Generic Formulations and Exports sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in SHARDACROP.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Conclusion: Sharda Cropchem Analyst Review Verdict for 2026

This Sharda Cropchem analyst review concludes that at Rs 904.80, SHARDACROP offers a defined risk-reward with a consensus target of Rs 1,100. The 52-week range of Rs 604.00 to Rs 1,297.00 provides context on the current entry point. Use this Sharda Cropchem analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on SHARDACROP.

Frequently Asked Questions: Sharda Cropchem Analyst Review 2026

What is the analyst target for Sharda Cropchem in 2026?

The analyst consensus target is Rs 1,100, with a bull case of Rs 1,380 and a bear case of Rs 820. Monitor Q1 FY27 earnings for confirmation as highlighted in this Sharda Cropchem analyst review.

Is Sharda Cropchem a good investment at Rs 904.80?

At Rs 904.80 with a P/E of 18x and a consensus target of Rs 1,100, this Sharda Cropchem analyst review is constructive for medium to long-term investors in the Agrochemicals – Generic Formulations and Exports sector. Always consult a SEBI-registered advisor before investing.

What is Sharda Cropchem’s 52-week high and low?

The 52-week high is Rs 1,297.00 and the 52-week low is Rs 604.00. At Rs 904.80, SHARDACROP is positioned within this range as noted in this Sharda Cropchem analyst review.

What are the key risks for Sharda Cropchem?

Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the Agrochemicals – Generic Formulations and Exports sector as assessed in this Sharda Cropchem analyst review.

Where can I track live data for Sharda Cropchem?

Track Sharda Cropchem’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Sharda Cropchem analyst review.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.